RUMORED BUZZ ON MD-224

AT-56Notwithstanding several setbacks, numerous MDM2 inhibitors have now progressed into late-stage medical advancement. New strategies have also been developed to boost the efficacy of MDM2 inhibitors and also to mitigate their on-goal toxicity. With this review, we summarize the progress and challenges in the event of the MDM2 qualified therapy.P